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device (LVAD) approved by the US Food and Drug Adminis-
tration (FDA) for bridging to transplantation therapy in end-
stage heart failure patients.1 Here we report the first
successful HeartMate II implantation in Taiwan.
A 37-year-old man, who suffered from advanced heart
failure as a result of ischemic cardiomyopathy, underwent
HeartMate II insertion because his heart function was
deteriorating despite maximal medical treatment. Anes-
thesia was conducted as in patients with severe heart
failure. A pulmonary artery catheter (PAC) was inserted,
because right ventricle (RV) failure is common and it is
a leading cause of morbidity and death after LVAD
implantation.2 The PAC was used for monitoring the
pulmonary artery pressure, optimizing the use of pulmo-
nary vasodilators and inodilators to decrease RV afterload
while maintaining ventricular contractility.
Intra-operative transesophageal echocardiography (TEE)
showed a hypokinetic heart with dilated left atrium and
ventricle. Mild mitral regurgitation (MR) and tricuspid
regurgitation (TR) were noted. There was pulmonary artery
hypertension with a TR pressure gradient of about* Corresponding author. Department of Anesthesiology, National
Taiwan University Hospital, 7, Chung-Shan South Road, Taipei, 100,
Taiwan.
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http://dx.doi.org/10.1016/j.jfma.2012.11.01344 mmHg. A mural apical thrombus (3 cm  3 cm) was found
in the left ventricle (LV).
The implantation steps were done under cardiopulmo-
nary bypass. The apical thrombus was removed after apical
coring. The alignment of mitral valve and inflow cannula
was checked by TEE.
Before LVAD was activated, we gently shook the heart in
a Trendelenburg position and needle punctured the LVAD
outflow tract to assist in de-airing of the intracardiac air
bubbles. Protamine was then administered slowly. Abrupt
elevations of pulmonary artery pressure (PAP) and central
venous pressure (CVP) and a plunge of blood pressure
developed shortly after activation of the LVAD pump. Signif-
icant ST segment elevation was noted in lead II. TEE showed
severe TR and flattening of the interventricular septum (IVS)
(Fig. 1). Protamine-induced pulmonary vasoconstriction, high
LVAD pump speed causing leftward IVS shift or right coronary
artery (RCA) air embolism-related RV dysfunction were
considered. Pump speed was decreased from 9600 rpm to
9000 rpm. Dobutamine, dopamine, and milirinone were
titrated to optimize RCA perfusion pressure, increase RV
contractility and decrease RV afterload. The patient condi-
tion was stabilized and transferred to the intensive care unit.
The endotracheal tube was removed the next day. He was
discharged to go home 1 month after surgery, and was
assessed as New York Heart Association functional class II.
TEE is essential to enable surgeons and anesthesiologists
to make prompt decisions during LVAD implantation. TEE is& Formosan Medical Association. All rights reserved.
Figure 1 (A) Left panel: A midesophageal two chamber view, sowing severe tricuspid regurgitation and flattening of interven-
tricular septum (IVS) shortly after initiation of HeartMate II pump. (B) Right panel: A transverse midesophageal four chamber view,
showing IVS returned to a neutral position after reducing the pump speed.
880 Y.-S. Lin et al.necessary for detecting cardiac structural and functional
abnormalities: ventricular dysfunction, valvular pathology,
mural thrombi, and atrial septal defect or patent foramen
ovale.3,4 AI and MS which decrease LVAD output should be
corrected if they are greater than a moderate degree.
There might be a transient RV dysfunction after LVAD
initiation: intracardiac air migrating to coronary arteries,
causing transient myocardial ischemia, high pump speed
producing RV failure because of a leftward shift of the IVS and
severe TR. Adjust the pump spin to produce a slight rightward
shift of the IVS with decrease in the degree of TR under TEE.
Careful patient selection, meticulous surgical and
anesthesia practice, use of inotropics and inodilators, with
PAC and TEE monitoring are important for successful
HeartMate II implantation.References
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